loadpatents
Patent applications and USPTO patent grants for Hellberg; Mark.The latest application filed is for "heterocyclic inhibitors of histamine receptors for the treatment of disease".
Patent | Date |
---|---|
Heterocyclic Inhibitors Of Histamine Receptors For The Treatment Of Disease App 20110257137 - Borchardt; Allen ;   et al. | 2011-10-20 |
Heterocyclic Inhibitors Of Histamine Receptors For The Treatment Of Disease App 20110237599 - Borchardt; Allen ;   et al. | 2011-09-29 |
Aminopyrazine Analogs For Treating Glaucoma And Other Rho Kinase-mediated Diseases And Conditions App 20080269249 - Hellberg; Mark ;   et al. | 2008-10-30 |
Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (LOX) and LOX-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies App 20060134172 - Shepard; Allan ;   et al. | 2006-06-22 |
Combinations of DP and FP type prostaglandins for lowering IOP Grant 6,166,073 - Dean , et al. December 26, 2 | 2000-12-26 |
Esters of non-steroidal anti-flammatory carboxylic acids Grant 5,998,465 - Hellberg , et al. December 7, 1 | 1999-12-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.